Al's Comment:

Toca 511 is an experimental gene therapy being tested for recurrent glioblastoma.  This study shows long lasting immunity - actually a cure - in mice.  Even when they tried to inject a new tumor into these mice, the mice rejected the tumor. 

---

Posted on: 04/06/2017

Retroviral replicating vector–mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity 

 

---

Click HERE to return to brain tumor news headlines.